NRx Pharmaceuticals

0 followers


NRx is a clinical-stage pharmaceutical company that is developing ZYESAMI (aviptadil acetate) for COVID-19 and NRX-101, the first oral therapeutic for the treatment of Acute Suicidal Behavior/Ideation (ASIB) in Bipolar Disorder.

Industries

Headquarters

Stage

Employees

Links

Org chart

Stephen Willard
CEO & Director

Stephen Willard

Collapse
Jonathan C. Javitt
Founder & Chief Scientist
Rick Panicucci
Chief Technology Officer
Seth Van Voorhees
Chief Financial Officer
Dennis K. McBride
Chief Strategy Officer & Senior Scientist
Matthew Duffy
Chief Business Officer
Philip T. Lavin
Chief Methodologist
Martin Brecher
Medical Director
M. Daniel Gordin
Regulatory Affairs Officer